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Surfacen®Surfacen® is a clinical surfactant preparation of porcine origin, partly depleted of cholesterol, which is widely
used in Cuba to treat pre-term babies at risk or already suffering neonatal respiratory distress. In the present
study we have characterized the interfacial behavior of Surfacen in several in vitro functional models, includ-
ing spreading and compression–expansion cycling isotherms in surface balances and in a captive bubble
surfactometer, in comparison with the functional properties of whole native surfactant puriﬁed from porcine
lungs and its reconstituted organic extract, the material from which Surfacen is derived. Surfacen exhibited
similar properties to native porcine surfactant or its organic extract to efﬁciently form stable surface active ﬁlms
at the air–liquid interface, able to consistently reach surface tensions below 5 mN/m upon repetitive compres-
sion–expansion cycling. Surfacen ﬁlms, however, showed a substantially larger and stable compression-driven
segregation of condensed lipid phases than exhibited by ﬁlms formed by native surfactant or its organic extract.
In spite of structural differences observed at microscopic level, Surfacen membranes showed a similar thermo-
tropic behavior to membranes from native surfactant or its organic extract, characterized by calorimetry or ﬂuo-
rescence spectroscopy of samples doped with the Laurdan probe. On the other hand, analysis by atomic force
microscopy of ﬁlms formed by Surfacen or by the organic extract of native porcine surfactant revealed a similar
network of interconnected condensed nanostructures, suggesting that the organization of the ﬁlms at the submi-
croscopic level is the essential feature to support the proper stability andmechanical properties permitting the in-
terfacial surfactant ﬁlms to facilitate the work of breathing.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Pulmonary surfactant is a complexmixture of lipids and speciﬁc pro-
teins that lines the alveolar epithelium and whose main function is to
reduce the surface tension at the air–liquid interface, avoiding the alve-
olar collapse and reducing the work of breathing [1–3]. The presence of
surfactant in the airways is absolutely necessary, being its absence, deﬁ-
ciency or inactivation associated with severe pulmonary diseases [4].
The Infant Respiratory Distress Syndrome (IRDS) is originated by an im-
maturity of the epithelium to synthesize and secrete a sufﬁcient amount
of lung surfactant. In the 80s of the past century, the success of the
pioneer therapeutic application of a pharmaceutical preparation of exog-
enous lung surfactant to treat infants with RDS [5,6] opened a new era inuímica, Facultad de Biología,
40 Madrid, Spain. Tel.: +34
l rights reserved.themanagement and critical care of preterm babies and has contributed
to save thousands of lives since then. Different clinical surfactant prepa-
rations have been developed and applied to treat babies in the last
decades, practically all of them deriving from animal sources, with com-
positional differences depending on the production method and the
variable supplementationwith additional lipid components [7]. Compar-
ative studies on the functional behavior of these preparations, in vitro
and in vivo, are scarce, and provide a limited correlation with their com-
position, structure and biophysical properties. Some clinical trials have
compared different commercial surfactant preparations,ﬁnding relevant
differences in clinically-relevant parameters [8,9]. This suggests that a
detailed analysis of structure–function correlations of clinical surfactant
preparations with respect to fully functional native surfactant can be of
interest both to identify and better understand essential features in the
surfactant system, and to optimize new strategies in the production of
more effective therapeutic surfactants.
Research in the pulmonary surfactant area during the last years
has been mainly focused, on the one hand, on attaining a detailed
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factant structures under functionally relevant conditions [2,10]. On
the other hand, pulmonary surfactant research has also pursued the
design of simpliﬁed surfactant preparations that could allow the sub-
stitution of the materials of animal origin, mainly through a proper
combination of synthetic lipids and peptides [11].
Amajorﬁndingwas that the particular lipid composition of surfactant
is evolutionarily optimized to sustain the segregation in surfactantmem-
branes andﬁlms of ordered and disordered phases,which has been relat-
ed with the particular properties of surfactant in terms of dynamics and
mechanical stability [12–16]. Some studies have analyzed towhat extent
clinical surfactants do capture this structural hallmark of native surfac-
tant and how much the existence of membrane phase segregation
could be also associated with proper functional properties [17–19]. In
the same line, a recent study has compared in detail the structure of
ﬁlms formed by different clinical surfactants, as seen under atomic
force microscopy (AFM) [20]. However, a direct comparison of both the
structure and biophysical properties of clinical surfactants with those of
their directly related source material is lacking, while it could illustrate
how the industrial procedures required to convert an animal-derived
material into a clinical product do actually modify its structure and func-
tional behavior.
In the present work, we have evaluated the structure and interfa-
cial properties of ﬁlms formed by a clinical surfactant preparation of
porcine origin, Surfacen®, compared with those of ﬁlms formed by
whole native surfactant puriﬁed from porcine lungs or by the organic
extract of porcine surfactant once reconstituted in the form of aque-
ous suspensions.
2. Materials and methods
2.1. Surfactants
Preparations of Surfacen®, a clinical surfactant used in the IRDS ther-
apy in Cuban hospitals [21], were obtained from the Centro Nacional de
Sanidad Agropecuaria (CENSA, Mayabeque, Cuba). Surfacen is obtained
from organic extracts of porcine bronchoalveolar lavages, which are
subjected to acetone precipitation to reduce their content of neutral
lipids. It is provided as a sterile white lyophilized powder, dosed in
50 mg phospholipid vials, which still contains the salts of the original
saline solution used to obtain the lavage [22]. To reconstitute Surfacen
dry powder, the proper amount of the surfactant is therefore weighted
and suspended in distilled water, with 60 min preincubation of the sus-
pension at 37 °C, with occasional vortexing, shortly before running
functional or structural experiments. Native porcine lung surfactant
(NPLS) was obtained from bronchoalveolar lavage of porcine adult
fresh lungs obtained from the slaughterhouse, as previously described
[23], and stored at −70 °C until its use. The organic extract of native
porcine lung surfactant (ENPLS) was obtained by chloroform/methanol
extraction of NPLS [24]. To prepare ENPLS aqueous suspensions, the re-
quired volume of the extract was ﬁrst dried under nitrogen and then in
UNIVAP for 2 h to remove traces of solvent, and then hydrated in buffer
5 mM Tris pH 7, 150 mM NaCl for 2 h at 45 °C with periodical stirring
(1250 rpm every 10 min) in a thermomixer. The different surfactant
preparations were quantitated through their phospholipid content, de-
termined using the phosphorus assay described elsewhere [25].
The lipid composition of NPLS, ENPLS and Surfacenwas analyzed and
compared by thin-layer-chromatography (TLC) in silica gel 60 plates
(Merck, Darmstad, Germany), using chloroform:methanol:water
(65:25:5,vol/vol/vol) as a mobile phase. Deﬁned amounts of phospha
tidylcholine (PC), phosphatidylglycerol (PG), phosphatidylethanol-
amine (PE), phosphatidylinositol (PI) and cholesterol were applied in
the sample plates as reference standards, and the different lipid bands
in the TLC plates were visualized under iodine vapors. Selected regions
of the TLC plates corresponding to the most important phospholipid
components of the surfactant samples were scratched from the platesand subjected to chloroform/methanol extraction, to determine the
molar proportion of each of themajor phospholipid classes by phospho-
rus quantitation. Themolecular species of the PC fraction of the different
surfactant samples were analyzed quantitatively by HPLC coupled to
mass spectrometry, with the generous assistance of Drs. Gemma Fabriàs
and Joseﬁna Casas, from the Institute of Advanced Chemistry of Catalo-
nia (CSIC) [26].
Analysis of protein content in Surfacen and other surfactant sam-
ples was carried out by electrophoresis under reducing conditions.
All analyzed samples contained 4.2 μg total phospholipids and were
separated in Tris–glycine gels using a Mini-protean IV (Bio-Rad) sys-
tem. Protein bands were then transferred onto nitrocellulose mem-
branes and analyzed by western blot. For SP-B analysis, membranes
were ﬁrst incubated with SP-B-antibody 1:5000 (rabbit antihuman
SP-B, Seven Hills Bioreagents), and then with peroxidase conjugated
goat Ig-G anti rabbit (SC-2004 from Santa Cruz Biotechnology). The
membranes were subjected to enhanced chemiluminescence assay
before exposing them to X-ray ﬁlms (Immobilon Western, Millipore
Corp., Billerica, MA). The same procedure was followed to detect
and analyze SP-C content (primary antiSP-C antibody W RAB-MSPC,
from Seven Hills Bioreagents).
2.2. Functional assays
2.2.1. Spreading assays in Langmuir surface balances
Suspensions of NPLS, hydrated ENPLS, or Surfacen were applied
with a syringe onto the interface of a specially designed T-shaped Tef-
lon trough (15 mL of subphase, buffer 5 mM TRIS pH 7, 150 mM
NaCl). The samples are applied in one end of the trough, while a pres-
sure sensor monitors the time-dependent spreading and lateral diffu-
sion of the surface active material arriving at the other end. Spreading
isotherms were obtained at 25 and 37±1 °C, upon spreading of dif-
ferent amounts of surfactant (5, 10, 25 or 50 μg total phospholipids).
2.2.2. Pressure–area (π–A) isotherms
π–A isothermswere obtained in a Langmuir surface balance (400 mL
buffered saline subphase) equipped with a Teﬂon ribbon barrier and a
Wilhelmy paper plate (NIMA Technology, Coventry, England) [27].
NPLS, hydrated ENPLS or Surfacen suspensions, prepared at 25 mg/mL,
were spread dropwise from a syringe at the surface of the balance, and
dynamic cycling of the spread ﬁlm was initiated after a 10 min pause
to allow for ﬁlm equilibration. Isothermswere obtained from ten succes-
sive compression–expansion cycles between maximal and minimal
trough areas, from 210 to 65 cm2, at a compression rate of 65 cm2/min.
Temperature was ﬁxed at 25±1 °C, a value at which the large surface
of the balance can be stably thermostatized. A large body of precedent
data has clearly established that differences in isotherms obtained at
25 °C actually reﬂect differences in surface behavior of the different ma-
terials, which, on the other hand, can be studied under conditions more
similar to physiological constraints in the captive bubble surfactometer
(see below). The isotherms presented in the ﬁgures are representative
experiments after at least three repetitions.
2.2.3. Captive bubble surfactometer (CBS)
The surface activity of the different surfactant samples was also
evaluated using a fully computer-controlled CBS evolved from the ap-
paratus described earlier [28], operated as described elsewhere [29].
The chamber of the CBS was ﬁlled with a buffer solution (5 mM
TRIS, 150 mM NaCl, pH 7) containing 10% (by mass) sucrose, to in-
crease the density of the buffer solution (1.04 g/mL) above that of
surfactants (~1.01 g/mL). The buffer solution was degassed and a
small bubble (50 μL, 3–4 mm diameter) was ﬂoated to the ceiling of
the sample chamber consisting of a concave agarose gel (1% w/w).
The solution was thermostated at 37 °C and left for 10 min to insure
100% humidity of the air bubble. To form the ﬁlm, 0.2 μL of the surfac-
tant sample (25 mg/mL) was deposited directly at the surface of the
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at the air–liquid interface of the bubble due to the density difference
with the buffer solution in the chamber. The shape of the bubble was
imaged over time by a video camera (Pulnix TM 7 CN) and the video
frames were digitized and saved to the computer's hard disk. A ﬁrst
5-min period following the application of surfactant into the chamber
allowed ﬁlm formation. Changes in surface tension over time were
monitored to obtain adsorption kinetics. The chamber was then
sealed and the bubble was expanded to a volume of 0.15 mL to mon-
itor post-expansion adsorption. Five minutes after the bubble was ex-
panded, quasi-static cycling commenced, in which the bubble size
was ﬁrst reduced and then enlarged in a stepwise fashion by altering
the internal volume of the chamber. Each step had a 3-s change in
volume followed by a 4-s delay where the ﬁlm was allowed to
“relax”. There was a 1-min delay between each of four quasi-static cy-
cles and a further 1-min delay between the quasi-static and the dy-
namic cycles. In the dynamic cycles, the bubble size was smoothly
varied over the same range as the last quasi-static cycle for 20 cycles
at a rate of 20 cycles/min. Bubble volume, interfacial area and surface
tension were calculated using height and diameter of the bubble as
previously described [30]. Data from initial and post-expansion ad-
sorption are presented as average values from 3 experiments and
quasi-static and dynamic cycling isotherms correspond to single rep-
resentative experiments.
2.2.4. Mechanical stability in CBS
To assess ﬁlm stability, the ﬁlms (ﬁlm coated bubble) were com-
pressed to theminimum possible surface tensionwithout ﬁlm collapse,
then perturbed by a pendulum hammer as previously described [29].
Five perturbations were carried out in succession, as this was judged
sufﬁcient in differentiating the samples. This test was carried out in
two ways: at the end of the full CBS protocol, i.e. after q-static and dy-
namic cycling of the ﬁlms, or immediately after the ﬁrst quasi-static
cycle.
2.3. Structural analysis
2.3.1. Epiﬂuorescence microscopy of surfactant ﬁlms
Films of NPLS, reconstituted ENPLS, or Surfacen were prepared by
spreading the suspensions at 5 mg/mL onto the buffered subphase
(0.5 M Tris pH 7 with 0.15 M NaCl) of a modiﬁed Langmuir balance
(Nima Technology, Coventry, UK), thermostated at 25±1 °C. The sus-
pensions were previously doped with 1 mol percent of the ﬂuorescent
lipid [1-palmitoil, 6-(N-7-nitrobenz-2oxa-1,3-diazol-4-il)-PC (NBD-PC),
added as an small aliquot of the probe in dimethylsulfoxide (DMSO). Al-
ternatively, monolayers were also prepared from ENPLS or Surfacen ex-
tracts (1 mg/mL) in chloroform/methanol (2:1, v/v). After 10 min
equilibration, the ﬁlms were compressed to the required pressure at a
compression rate of 25 cm2/min. After 10 min equilibration, the ﬁlms
were transferred to glass coverslips previously immersed in the
subphase, to obtain continuously varying surface pressure (COVASP)
ﬁlms as described previously [31]. This technique allows transfer and
characterization of ﬁlms compressed at different surface pressures, in
the same glass support. Epiﬂuorescence images of the supported LB
ﬁlms were acquired in a Zeiss Axioplan II ﬂuorescence microscope (Carl
Zeiss, Jena, Germany) equipped with the appropriate ﬂuorescence ﬁlters
for observation of NBD-PC ﬂuorescence (maximum ﬂuorescence emis-
sion at 520 nm).
2.3.2. Atomic force microscopy (AFM) of surfactant ﬁlms
Samples for AFM were prepared upon transfer of surfactant ﬁlms
onto freshly cleaved mica surfaces using the classic Langmuir–Blodgett
method [32]. NPLS or Surfacenmonolayers were prepared by spreading
organic extract solutions (1 mg/mL) onto the buffer subphase of the
surface balance. The ﬁlms were then compressed until reaching the re-
quired surface pressure (37 mN/m) and transferred ontomica supportsthat were previously immersed in the subphase, while the computer-
controlled balance compensates with compression the loss of material
to maintain the target pressure constant. The AFM images were
obtainedwith aMultimodeNanoscope IIIA equippedwith a type J scan-
ner (Veeco Instruments, Santa Barbara, CA), operated in tapping mode.
Tips used were RESTP phosphorus (n) doped silicon probes with a typ-
ical radius of less than 10 nm, nominal spring constant of 40 mN/m and
resonance frequency between 266 and 309 KHz. Topography and phase
images were recorded from each sample with 512 scan lines and a
frame rate of 0.5 Hz.
2.3.3. Calorimetry
The analysis of the thermotropic properties of surfactant samples
was carried out by differential scanning calorimetry (DSC) of the sam-
ples in a VP-DSC MicroCal calorimeter (Baltimore, MD). The sample
cells were loaded with 0.5 mL of 5 mg/mL of NPLS, ENPLS or Surfacen
suspensions, while the reference cell was loaded with an equivalent
aliquot of buffer. Ten consecutive scans were obtained over a temper-
ature from 5 to 60 °C at a scan rate of 30 °C/h. The resulting thermo-
grams were processed to subtract the baseline and to estimate the
enthalpy associated and the transition temperature (Tm) of the
main transitions using the Origin Software (Northampton, MA). The
DSC curves presented in the ﬁgures are representative of at least
three different experiments.
2.3.4. LAURDAN ﬂuorescence
Thermotropic phase transitions inNPLS, ENPLS and Surfacen suspen-
sions were also characterized by following the temperature-dependent
shift of the ﬂuorescence of a trace (1% with respect to phospholipid,
mol/mol) of the ﬂuorescent probe LAURDAN, as previously described
[33]. LAURDAN was incorporated into surfactant samples as a small
dimethylsulfoxide aliquot, and the ﬁnal phospholipid concentration
was of 10 μg/mL. The ﬂuorescence spectra of all samples were recorded
in an Aminco-Bowman Series 2 luminescence spectrometer equipped
with thermostated cells, using an excitation wavelength of 370 nm
and recording the emission between 400 and 550 nm,within a temper-
ature range of 10 to 60 °C. The results were expressed as a generalized
polarization function (GPF), deﬁned as GPF=(IB− IR)/IB− IR being IB
and IR the intensities at the blue and red edges of the emission spectrum,
respectively [33,34].
2.4. Data reproducibility and statistics
Whenpossible, theﬁgures represent themean±S.D. after averaging
data from three independent experiments, with at least two different
batches of each surfactantmaterial. Langmuir and CBS compression–ex-
pansion experiments are illustrated as representative isotherms of each
type of surfactantmaterial. Statistical signiﬁcance of differences in com-
position or surface behavior was analyzed using one way analysis of
variance (ANOVA). Particularly, Holm–Sidak method was applied for
multiple comparison versus control group, with signiﬁcance level=
0.05. To compare two particular groups the Mann–Whitney Rank Sum
Test was applied.
3. Results
3.1. Lipid and protein composition of surfactant preparations
Fig. 1 illustrates a comparative compositional analysis of the lipid
fraction in NPLS, ENPLS and Surfacen preparations. The three materials
contain more than 90% by weight of phospholipids, being phosphati
dylcholine (PC) the main phospholipid class, which accounts for
79.5±1, 81.9±0.3 and 74.1±2.1% of phospholipid mass in NPLS,
ENPLS and Surfacen, respectively. The main anionic phospholipid in
our NPLS and ENPLS preparations is phosphatidylinositol (PI), whilst
phosphatidylglycerol (PG) is the main negatively charged phospholipid
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amount of PE that is not resolved in the TLC system used. However,
we know from previous studies that PE is a very minor phospholipid
class in these preparations. All the batches analyzed of the three surfac-
tant preparations contained similar proportions of PI, in the order of 10–
15%, being the proportion of PG that showing the largest differences.
NPLS and ENPLS batches always contained signiﬁcantly lower amounts
of PG, in the order of 4–8%, than Surfacen, which contained 12–16% PG.
The analysis of phospholipid molecular species in the PC fraction of the
three surfactant samples revealed that dipalmitoylphosphatidylcholine
(16:0/16:0, DPPC) was always the main species, accounting for around
70% of PC inNPLS and ENPLS andup to 78–80% of PC in Surfacen. Interest-
ingly, the proportion of other disaturated PC species, palmitoylmiristoyl-
PC (16:0/14:0, PMPC), was lower in Surfacen (~9%) than in NPSL and
ENPSL (11–14%). The lower proportion of PMPC with increased amounts
of DPPC possibly reﬂects compositional differences in the sourcematerial
of Surfacenwith respect to that of ourNPLS andENPLSpreparations, likely
as a consequence of differences in animal strains, nutrition and other en-
vironmental variables, as it has been reported [35]. The TLC in Fig. 1 also
illustrates a major difference in the lipid composition of Surfacen com-
pared toNPLS andENPLS. Production of Surfacen involves an acetone pre-
cipitation step, which reduces signiﬁcantly the content of cholesterol,
from 3.2±0.2% to 0.8±0.2% with respect to phospholipid by mass.
On the other hand, Fig. 2 shows illustrative western blots compar-
ing the relative content of proteins SP-B and SP-C in the different
samples studied. Surfacen contains well-detectable proportions of
both proteins, in the order of 0.7% SP-C and 0.4% SP-B with respect
to phospholipid by mass, comparable in broad terms to the amounts
of SP-B and SP-C present in a well known clinical surfactant like
Curosurf (samples generously provided by Prof. Adolf Valls, fromHos-
pital Cruces, Bilbao, Spain).
3.2. Interfacial properties of surfactant ﬁlms
Fig. 3 compares π–t spreading kinetics of suspensions of NPLS,
ENPLS and Surfacen at the interface, at 25 and 37 °C. The threeFig. 1. Compositional analysis of the lipid fraction of native surfactant and Surfacen. a) Th
Surfacen. 100 μg of total phospholipid were applied from each sample in the TLC plate and
dred micrograms of each of the indicated standard lipid classes was applied in the same TL
classes in NPLS, ENPLS and Surfacen as determined by phosphorus quantitation of each of th
tically signiﬁcant differences (pb0.05). c) Quantitative compositional proﬁle of molecular s
mined by mass spectrometry lipidomic analysis of the PC band obtained from TLC.surfactant materials adsorb very efﬁciently at the interface at 37 °C,
producing equilibrium surface pressures of around 43 mN/m in less
than a minute. The amount ofmaterial required to reachmaximal pres-
sure somehow differs in the different samples. Ten microgram of NPLS
is enough to form a ﬁlm at maximal pressure, while at least 25 μg is re-
quired for ENPLS or Surfacen to reach similar equilibrium values. Differ-
ences in spreading capabilities were maximized when the different
materials were tested at 25 °C. The whole native NPLSmaterial showed
signiﬁcantly better adsorption properties than ENPLS or Surfacen,
which behaved very similarly. Maximal pressures reached by Surfacen
upon adsorption at either 25 °C or 37 °C were indistinguishable from
those reached by ENPLS, but signiﬁcantly lower than pressures pro-
duced by equivalent amounts of NPLS (pb0.05).
To analyze the ability of interfacial ﬁlms formed by adsorption of the
three compared materials to reach very low surface tension (high sur-
face pressure) under compression, we run compression–expansion cy-
cling isotherms in a Langmuir surface balance (see Fig. 4), at 25 °C. All
the ﬁlms exhibited qualitatively similar isotherms, with long exclusion
(compression) and reinsertion (expansion) plateaus, reaching surface
pressures above 70 mN/m upon cyclic compression. None of the ﬁlms
reached pressures of 70 mN/m during the ﬁrst compression cycle, al-
though ﬁlms formed by spreading of whole NPLS produced signiﬁcantly
higher pressures than ENPLS or Surfacen ﬁlms (pb0.05). Remarkably,
the successive compression–expansion cycles improved progressively
the properties of the three materials, which consistently reached maxi-
mal pressures from the third compression cycle, as it can be observed in
the insets of Fig. 4. The ﬁlms of NPLS, ENPLS or Surfacen were very sta-
ble, as they maintained minimal pressures above 25 mN/m during all
the cycles. In this respect, ﬁlms formed by Surfacen maintained signiﬁ-
cantly higher minimal pressures (pb0.05) than ﬁlms made by ENPLS.
To compare the biophysical behavior of the surfactant materials
undermore physiologically relevant conditions of high surfactant con-
centrations and physiological temperature, Fig. 5 summarizes adsorp-
tion and quasi-static and dynamic cycling isotherms obtained in a
captive bubble surfactometer. The three materials, NPLS, ENPLS and
Surfacen, showed absolutely comparable initial adsorption propertiesin-layer-chromatographic (TLC) analysis of the lipid composition of NPLS, ENPLS and
developed using chloroform/methanol/water (65:25:5, v/v/v) as elution system. Hun-
C plate as a reference. b) Quantitative compositional proﬁle of the main phospholipid
e TLC bands in the regions deﬁned in the chromatogram. The asterisk indicates statis-
pecies in the PC fraction of a representative batch of NPLS, ENPLS and Surfacen, deter-
Fig. 2. Analysis of SP-B and SP-C content in Surfacen and native surfactant complexes
by Western blot. Western blot analysis using anti-SP-B (left) and anti-SP-C (right) pri-
mary antibodies of samples of NPLS, ENPLS and Surfacen (Surf) suspensions. For com-
parison, an equivalent aliquot of the clinical surfactant Curosurf has been loaded into
one lane (Curo), as well as the indicated reference amounts of puriﬁed porcine SP-B
or SP-C. In the SP-C gel, the lane labelled SP-B was loaded with 2 μg of puriﬁed porcine
SP-B to illustrate the speciﬁcity of the anti-SP-C antibody.
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equilibrium surface tensions around 23 mN/m within few seconds
(Fig. 5a). Post-expansion adsorption was also statistically comparable,
indicating that the excess of the three materials could somehow main-
tain association with the ﬁlms, so that upon expansion and opening of
new interface they could rapidly re-spread and restore theminimal ten-
sion. These re-spreading capabilities are conﬁrmed along the quasi-static
and dynamic compression–expansion isotherms of the ﬁlms formed by
the three materials (Fig. 5b). Quasi-static cycling showed that NPLS,
ENPLS andSurfacen required at least aﬁrst compression cyclewith a sur-
face area reduction around 34–44% to achieve aminimal surface tension
of 2–4 mN/m. During the second compression, only a reduction of
around 20% in area is needed for NPLS and ENPLS ﬁlms to reach themin-
imum surface tension. The same behavior is achieved from the third
cycle by Surfacen ﬁlms (Fig. 5b, Table 1). The ﬁrst q-static compression–Fig. 3. Interfacial adsorption of Surfacen and native surfactant preparations. π–t isotherms h
NPLS (left), ENPLS (center) or Surfacen (right) suspensions in a modiﬁed Langmuir balance
pressure reached by samples at 25 s (π25 s) or 100 s (π100 s) after applying.expansion isotherm was always very different from the fourth one, with
markedly larger changes in area and hysteresis, which disappeared in
the successive cycles. This could indicate that the three compared mate-
rials are efﬁcient in promoting a progressive compression-driven reorga-
nization of the ﬁlms during the successive compression–expansion
cycles. Upon cycling under dynamic regime, at physiologically relevant
rates, all the ﬁlms reached consistently low surface tensions with practi-
cally no hysteresis and minimal area reductions below 20% (Fig. 5b,
Table 1), while maintaining reduced maximal tensions.
Films formed by NPLS, ENPLS or Surfacen were all highly stable
when subjected to mechanical perturbations. Fig. 6 illustrates how
ﬁlms formed by the three materials were able to maintain low ten-
sions ≤5 mN/m once the compressed states were subjected to repet-
itive mechanical perturbations, either after a single quasi-static
compression cycle or after 4 q-static and 20 dynamic compression–
expansion cycles.
3.3. Structure of surfactant ﬁlms
Compositional differences betweenNPLS, ENPLS and Surfacenwould
anticipate differences in the structure of the different ﬁlms, in spite of
their comparably efﬁcient behavior at the interface. Epiﬂuorescence im-
ages of ﬁlms formed by spreading NPLS, ENPLS or Surfacen aqueous sus-
pensions, doped with 1 mol% of the ﬂuorescent phospholipid probe
NBD-PC, at the air–liquid interface and compressed to different surface
pressures, are shown in Fig. 7. These images were taken at surface pres-
sures near to the large plateau of the compression isotherm,wheremax-
imal segregation of condensed phase domains has been reported
[14,15]. The three types of ﬁlms exhibited segregated dark domains, in-
dicative of the existence of ordered regions with packing excluding the
bulkyﬂuorescent probe, but these condensed domains showed very dif-
ferent morphology in the materials compared. Films formed by whole
NPLS, segregated under compression conspicuous but very small do-
mains, which reached a maximal size at around 38 mN/m. When theave been obtained upon spreading 5 (▲), 10 (♦), 25 (■) or 50 (●) μg phospholipid of
thermostatized either at 25 °C (upper panels) or 37 °C (lower panels). Insets: surface
Fig. 4. π–A cycling isotherms of Surfacen and native surfactant ﬁlms in a Langmuir balance. Ten π–A compression–expansion cycling isotherms have been recorded from NPLS (left),
ENPLS (center) or Surfacen (right) ﬁlms formed by adsorption of the corresponding aqueous suspensions on top of a Tris 5 mM pH 7 subphase containing NaCl 150 mM and
thermostatized at 25 °C. Compression rate was 65 cm2/min. Marked are the ﬁrst (red) and last (blue) compression–expansion cycle. Insets: maximal (πmax) and minimal surface
pressure (πmin) plotted vs. the number of cycle for NPLS (squares), ENPLS (diamonds) or Surfacen (circles) ﬁlms.
2761O. Blanco et al. / Biochimica et Biophysica Acta 1818 (2012) 2756–2766NPLS ﬁlms were compressed at pressures higher than that, the size of
the domains progressively decreased as well as the apparent contrast
between condensed domains and the bright background, so thatFig. 5. Surface activity of Surfacen and native surfactant preparations as assessed in the
captive bubble surfactometer. (a) Interfacial adsorption of NPLS (squares), ENPLS (di-
amonds) or Surfacen (circles) suspensions (100 nL, 25 mg/mL) onto the interface of
an air bubble in the CBS, thermostatized at 37 °C. Plots compare kinetics upon initial
adsorption (IA, left) and after bubble expansion (PEA, right). (b) Quasi-static (upper
panels) and dynamic (lower panels) compression–expansion cycling isotherms of bub-
bles coated with NPLS (left), ENPLS (center) or Surfacen (right) ﬁlms.domains were no longer observed at pressures above the plateau of
the isotherm, >45 mN/m. Domains segregated upon compression of
ﬁlms formed by spreading aqueous suspensions of ENPLS were much
smaller and markedly less dark than those observed in NPLS ﬁlms. Do-
mains in ENPLS ﬁlms seemed also to progressively disappear at pres-
sures above 38–40 mN/m, together with the progressive appearance
of bright structures, presumably constituted by three-dimensional sur-
factant aggregates associated with the interfacial ﬁlm. In contrast to do-
mains in NSPL or ENPSL ﬁlms, domains segregated upon compression of
Surfacen ﬁlms showed a high contrast, which was maintained at all the
pressures analyzed. Furthermore, Surfacen domains were larger and
occupied a larger fraction of area than condensed domains in NPLS or
ENPLS. At pressures above 45 mN/m, bright spots of structures presum-
able protruding in the Z-axis were also present in Surfacen ﬁlms,
although much smaller and more diffusely distributed than those seen
in ENPLS layers.
To explore the nature of the marked differences between the lateral
structure of compressed ENPLS and Surfacen ﬁlms, we have analyzed
their organization at the submicrometer and nanometer scales by
AFM. At large scale, AFM images conﬁrm the presence of more numer-
ous and larger condensed domains in Surfacen ﬁlms than observed in
ﬁlms formed by ENPLS. Fig. 8 compares illustrative topology and
phase AFM images of ENPLS and Surfacen ﬁlms compressed to
37 mN/m, the surface pressure at which maximal segregation ofFig. 6. Stability of compressed Surfacen and native surfactant ﬁlms against mechanical
perturbations. Bars compare minimal surface tension reached by ﬁlms of NPLS, ENPLS
or Surfacen in the captive bubble, before (black bars) and after (grey bars) introduction
of 5 consecutive mechanical perturbations discharged on the CBS chamber by a
pendulant hammer. Stability of bubbles after one single quasi-static compression
cycle (left panel) has been compared with that of bubbles undergoing 4 quasi-static
and 20 dynamic compression–expansion cycles (right panel) before introducing the
perturbations. Means and standard deviations are shown after averaging 5 different
experiments.
Table 1
Parameters deﬁning quasi-static and dynamic compression–expansion isotherms of ﬁlms formed by NPLS, ENPLS or Surfacen, as assessed in the captive bubble surfactometer.
Surfactant Quasi-static Dynamic
Cycle 1 Cycle 4 Cycle 20
γmin % Comp. γmax γmin % Comp. γmax γmin % Comp. γmax
NPLS 2.5±0.31 34.4±6.4 23.9±0.8 2.6±0.6 17.6±2.6 25.8±2.7 2.9±0.57 14.3±2.3 28.4±1.3
ENPLS 2.0±0.17 43.2±6.6 25.7±0.6 2.5±0.6 16.4±2.1 29.5±1.2 2.5±0.7 14.0±2.0 31.9±0.4
Surfacen® 3.4±0.71⁎,⁎⁎ 34.9±8.3 25.5±1.0⁎ 3.1±0.6 20.9±3.6 27.5±1.5 2.82±0.49 18.3±1.8⁎ 29.6±2.91
γmin: minimum surface tension (mN/m); γmax maximum surface tension (mN/m); % comp.: percentage of compression required to reach γmin.
⁎ Signiﬁcant difference between NPLS and ENPLS or Surfacen® (pb0.05).
⁎⁎ Signiﬁcant difference between ENPLS and Surfacen® (pb0.05).
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scanned, AFM images show the presence of well-deﬁned micron-size
domains, presumably constituted by DPPC-enriched condensed phase,
as they show size and distribution that are fully comparable to those of
the dark domains observed under epiﬂuorescence microscopy. The
higher resolution of AFM shows the clear differences in size and mor-
phology between the segregated domains in Surfacen ﬁlms and those
in ENPLS layers. Domains in Surfacen are larger (diameter 6.8±2 μm)
and have a polymorphic ﬂower-like morphology, whilst condensed do-
mains in ENPLS are signiﬁcantly smaller (diameter 2.3±0.5 μm) and
have a much more rounded shape. The expanded phase of both ENPLS
and Surfacen, which appeared uniformly bright under the ﬂuorescence
microscope, showed a heterogeneous structure at the submicroscopic
scale. In the layers of the two materials compared, a percolated matrix
of topologically higher, presumably condensed, regions coexists with
isolated nanoregions of reduced height, likely consisting of less packed
liquid-expanded lipid domains. The contrast between the two types of
nanoregions is somehowmore evident in the phase-mode AFM images.
Interestingly, the difference in height between the two regions in
Surfacen (~3 Å) is shorter than that observed in ENPLS ﬁlms (~7 Å). A
detailed observation of the structure of ENPLS and Surfacen ﬁlms also re-
veals the presence of higher structures associated with the ﬁlms. In the
ENPLS layers compressed to 37 mN/m one can distinguish the presence
of more or less rounded structures of around 100–200 nm of diameter,
uniformly distributed at the surface of the ﬁlms but always on top of re-
gions of higher liquid-condensed phase. These round protruding struc-
tures do not almost show contrast in the phase images, where they
look comparable to liquid-expanded regions. Such round structuresFig. 7. Structure of Surfacen and native surfactant ﬁlms as examined by epiﬂuorescence mic
Surfacen ﬁlms doped with 1 mol% with respect to phospholipids of NBD-PC, transferred dur
indicated surface pressures were sampled at different positions of the corresponding COVAS
a Langmuir surface balance thermostatized at 25 °C, and were compressed at a rate of 25 cwere not practically seen in the Surfacen ﬁlms. On the other hand, both
ENPLS and Surfacen ﬁlms contained uniformly distributed small clusters
of around 30–50 nm, associated almost invariably with liquid-expanded
regions and with practically no contrast in the phase images, indicating
that they could consist of protruded lipid projections sticking out of the
plane of the ﬁlms. Apart of the differences in the structures protruding
out of ENPLS and Surfacen ﬁlms, the morphology of the two types of
layers was entirely comparable with respect to the coexistence of
liquid-condensed and liquid-expanded nanoregions and the nanometer
scale.3.4. Thermotropic behavior of surfactant complexes
Fig. 9 summarizes experiments characterizing the thermotropic
properties of NPLS, ENPLS and Surfacen complexes, by calorimetry and
ﬂuorescence spectroscopy.Membranes of NPLS and ENPLS showed char-
acteristic DSC thermograms (Fig. 9, left panel), similar to those previously
published [12,13]. Both types of materials exhibited a broad calorimetric
transition, presumably from ordered to disordered lipid phases, associat-
ed with an asymmetric endothermic peak, which ends abruptly at tem-
peratures close to 37 °C. Thermogram of Surfacen showed a somehow
different morphology, with a less asymmetric peak and more signiﬁcant
contributions at the higher temperature range, above 30 °C. The broad
transition of Surfacen ends at temperatures slightly higher, around
39 °C, than those deﬁning the end of transition for NPLS and ENPLS.
The enthalpy associated to the transition in Surfacen membranes, 2.6±
0.2 Kcal/mol °C, is not signiﬁcantly different to that associated to theroscopy. Typical images obtained under a ﬂuorescence microscope of NPLS, ENPLS and
ing compression onto glass coverslips using the COVASP technology [31]. Images at the
P ﬁlm. The ﬁlms were spread from aqueous suspensions onto the air–liquid interface of
m2/min. All the images have a length of 300 μm.
Fig. 8. Structure of Surfacen and native surfactant ﬁlms as examined by AFM. Typical images obtained by AFM of ﬁlms formed by spreading organic solutions of ENPLS (left) or
Surfacen (right) on a Langmuir surface balance thermostated at 25 °C, compressed at 25 cm2/min up to 37 mN/m and transferred at constant pressure onto freshly exfoliated
mica supports. The ﬁgure compares topology images taken under tapping mode (left side of each panel) and images under phase contrast mode (right side of each panel), at
three different magniﬁcations covering the lateral distance indicated.
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0.1 Kcal/mol °C) samples.
The thermotropic proﬁle of the samples has also been compared an-
alyzing the blue-to-green shift of the emission of a trace of the probe
LAURDAN, incorporated into the different complexes. The right panel
in Fig. 9 compares the change with temperature of the Generalized Po-
larization Function of Laurdan (evaluating the spectral shift of the probe
emission) integrated in NPLS, ENPLS or Surfacen membranes. These
proﬁles reﬂect the changes in the microenvironment of the probe
when passing from the highly packed dehydrated state of the mem-
branes in the ordered states, at low temperatures, to the more disor-
dered, well-hydrated environment of the probe in membranes in a
liquid-disordered state, at temperatures above the phase transition.
The threematerials compared show indistinguishable Laurdan thermo-
tropic proﬁles, indicating that temperature-driven transitions in all of
them are sensed similarly by a probe that partitions equally in ordered
and disordered phases.Fig. 9. Thermotropic behavior of Surfacen and native surfactant membranes. Left
panel) Typical differential scanning calorimetry thermograms of NPLS, ENPLS and
Surfacen suspensions (5 mg/mL phospholipid). Right panel) Thermotropic proﬁle of
generalized polarized function (GPF) of the ﬂuorescence of NPLS, ENPLS and Surfacen
membranes doped with the probe LAURDAN (1% molar with respect to phospholipids).4. Discussion
The present study has approached a detailed characterization of the
structure and functional properties of Surfacen, a surfactant preparation
currently in use to treat neonates at risk of suffering IRDS. This clinical
surfactant has contributed to reduce dramatically the mortality of pre-
term babies in Cuba in the recent years [21,36]. Surfacen is obtained
from the organic extract of lipid/protein surfactant complexes pelleted
from porcine bronchoalveolar lavage, once subjected to acetone precip-
itation to reduce the proportion of cholesterol to less than 20-25% of the
original content of cholesterol in the source material. Considering the
method of production and the lipid and protein composition, Surfacen
could be considered a porcine version of BLES, a clinical surfactantobtained from bovine lung lavage, which has been extensively charac-
terized [37–40]. Considering the starting material and the production
method of Surfacen and BLES, these natural preparations should contain
signiﬁcant proportions of surfactant proteins SP-B and SP-C, the main
protein components responsible for the formation and the dynamic
properties of functional surfactant ﬁlms at the interface [2,29]. We
have conﬁrmed that Surfacen contains signiﬁcant amounts of both
SP-B and SP-C, comparable to those accompanying phospholipids in
chloroform/methanol surfactant extracts, and also similar to those
found in Curosurf, another surfactant preparation of natural origin
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tation is alsowidely used to remove protein components frombiological
samples and there was a possibility that, apart from removing choles-
terol, it could also remove some of the protein moiety from the surfac-
tant extracts. We show here that Surfacen still contains a considerable
amount of SP-B and SP-C after acetone precipitation, although the abso-
lute proportion of SP-B could be partially reduced comparedwithmate-
rial that did not go through acetone treatment (see SP-B bands in the gel
of Fig. 2). A main compositional difference of both BLES and Surfacen
with respect to their source material, the whole native surfactant and
its organic extract, is the signiﬁcant reduction in cholesterol content.
Cholesterol has dramatic effects in the structure, dynamics and surface
properties of surfactant. It has been demonstrated that the presence of
physiological proportions of cholesterol modulates the lateral segrega-
tion of ordered and disordered lipid phases in surfactant membranes
[13] and ﬁlms [41,42], as well as the dynamic behavior of phospholipid
species in terms of their diffusion coefﬁcient [12]. On the other hand ex-
acerbated amounts of cholesterol have shown deleterious effects on
surfactant interfacial activity [37,39], which motivated the removal of
a main fraction of the cholesterol originally present in the naturalmate-
rials used as a source of practically all the clinical surfactants currently in
use [7]. To our knowledge, this is one of very few studies in which the
structure and functional properties of a clinical surfactant has been
compared in detail with those of the material from which it is derived.
The study offers in our opinion a good opportunity to analyze to what
extent the procedures involved in the extraction,manipulation and pro-
duction, storage and distribution of a clinical surfactant preserves the
functional properties of the whole native surfactant complexes, and
on the other hand, provides complementary information to deﬁne the
essential features deﬁning a properly active surfactant.
Surfacen and ENPLS suspensions exhibit a signiﬁcantly slower in-
terfacial adsorption than lipid-protein complexes from full NPLS,
which has been usually interpreted in terms of a faster cooperative
adsorption of surfactant promoted by protein SP-A [43]. Still, Surfacen
shows in the functional tests a very good surface activity, comparable
to that exhibited by suspensions of the material extracted from natu-
ral surfactant using organic solvents, in terms of i) rapid adsorption to
the air–liquid interface (equilibrium surface pressures ≥40 mN/m in
less than 5 min in the Langmuir trough; surface tensions b25 mN/m
in less than 1 min in the CBS), ii) ability to reach very high surface
pressures (low surface tensions, b5 mN/m) upon repetitive compres-
sion while maintaining high minimal pressures (low maximal ten-
sions, ≤30 mN/m) during expansion, and iii) good stability to
sustain the lowest tensions (b5 mN/m) upon mechanical perturba-
tion of compressed surface ﬁlms. Surfacen even exhibits signiﬁcantly
higher minimal surface pressures than native surfactant and its or-
ganic extract in ﬁlms cycled at the Langmuir balance, and a concom-
itant trend towards lower maximal tensions when cycled in the CBS.
The good surface activity of Surfacen is likely related with an appro-
priate content of hydrophobic surfactant proteins, particularly of
SP-B. Enough proportion of SP-B, ≥0.4% with respect to phospholipid
by mass, has been shown to be essential both to permit surface ﬁlms
reaching the lowest tensions upon minimal area reduction during
compression and to sustain minimal tensions even after strong me-
chanical perturbations [29].
In spite of the remarkable similarity of the interfacial activity of
Surfacen with respect to that of ﬁlms formed by suspensions of porcine
surfactant organic extracts, the lateral structure of the ﬁlms formed by
the two materials showed marked differences. Compression originates
in Surfacen ﬁlms the segregation of condensed domains that were signif-
icantly larger, more polymorphic and exhibited higher contrast than
those observed in ENPLS or NPLS ﬁlms. This higher contrast is likely relat-
ed with the relatively higher proportion of DPPC in Surfacen compared
withNPLS or ENPLS. The polymorphicﬂower-like shape of condenseddo-
mains in Surfacen can be attributed to the gel-like solid character of
DPPC-enriched domains segregated in the absence of cholesterol, as ithas been observed in othermodel systems [44], whilst themore rounded
small domains in NPLS and ENPLS likely consist of segregated ﬂuid
liquid-ordered phase such as that typical of cholesterol-containing
DPPC-enriched regions. Furthermore, condensed domains segregated in
Surfacen persisted upon compression of the ﬁlms up to very high pres-
sures, above 38 mN/m, while virtually disappeared in NPLS or ENPLS
ﬁlms compressed to a similar extent. The remixing of condensed domains
in surfactant ﬁlms compressed beyond threshold pressures has been at-
tributed to the presence of cholesterol [41,42]. Removal of cholesterol in
Surfacen could therefore contribute to prevent the structural transforma-
tion that occurs in ﬁlms of natural surfactant compressed up to the
so-called squeeze-out plateau, occurring at around 45 mN/m, whichmo-
lecular nature is still not completely understood. It has been proposed
that this level of compression induces a conversion of the condensed
micron-sized domains into much smaller nanodomains, whose size pre-
vents observation under the optical microscope [45]. However, the con-
nection between this lateral restructuration and the presence of
cholesterol has not been explained yet. The results of the AFM experi-
ments shown here suggest that the removal of cholesterol prevents
the formation of certain three-dimensional protrusions, which seem
to be originated from the condensed domains in ENPLS ﬁlms. We pro-
pose that in the presence of cholesterol, condensed domains segregated
upon compression of full compositionally complex surfactant ﬁlms actu-
ally consist of a ﬂuid liquid-ordered (LO) type of phase. This LO phase
could have limited stability at high pressures, leading to partial
squeeze-out of material, which could originate a redistribution of
ﬂuorescently-labeled components, giving a homogeneous appearance
under the low spatial resolution of the epiﬂuorescence images. This
could also be the reason why ENPLS ﬁlms appear as associated with nu-
merous protruded lipid aggregateswhen analyzed under AFM. It remains
to be determined whether protruded structures have a differentiated
lipid composition and whether these three-dimensional projections
have a thickness consistent with the formation of multilayer stacks. A
previous structural study of BLES ﬁlms, in the absence or presence of
physiological proportions of cholesterol, found that cholesterol forms do-
mains within liquid-ordered domains [38]. The present results suggest
that segregation of cholesterol-enriched domains within the condensed
phase could in fact precede the possible pressure-promoted extrusion
of cholesterol-enriched clusters, to end in a cholesterol-depleted ﬁlm
with higher mechanical stability. The observation under AFM of ﬁlms
subjected tomore than one cycle of compression revealed the presence
of numerous permanently-segregated structures thatmaintain associa-
tion with the interfacial ﬁlm but are highly deformable upon scanning
with the AFM tip (not shown). These permanently segregated struc-
tures could be the basis of the irreversible depuration/reorganization
of surfactant ﬁlms that occurs during compression, likely related with
the progressive loss of hysteresis observed in subsequent compres-
sion–expansion cycles at the CBS. Unfortunately, the higher complexity
of ﬁlms subjected to repetitive compression–expansion cycling, includ-
ing the presence of this highly deformable three-dimensional struc-
tures, prevented a more detailed analysis of the processes involved in
compression-driven reorganization of surfactant ﬁlms, which will be
the subject of further future studies. In the absence of cholesterol, segre-
gated domains would really consist of a liquid-condensed (LC) solid
phase, hardly deformable at high pressures, explaining why Surfacen
ﬁlms lack large protruded lipid aggregates as seen under AFM. The rel-
atively lower solubility of the bulky ﬂuorescent probe into the solid do-
mains of Surfacen would explain their darker appearance with respect
to the LO domains in NPLS or ENPLS ﬁlms. A more efﬁcient segregation
of DPPC-enriched ordered LC-like phases could also explain the slight
shift of the end of the calorimetric transition in Surfacenmembranes to-
wards higher temperatures. The differences in lipid organization and
packing could be practically restricted to the local regions where con-
densed domains nucleate, without producing signiﬁcant differences in
the average hydration state of the different membranes as a whole,
according to the information reported by Laurdan.
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do not seem to be related with detectable important differences in
surface activity. Careful examination of the structure of the two
types of ﬁlms at the submicroscopic scale accessible by AFM reveals
that once cholesterol has somehow promoted the protrusion into
the third dimension of material from ENPLS ﬁlms, both ENPLS and
Surfacen ﬁlms become constituted by a remarkably similar submicro-
scopic network of interconnected condensed phase. Exclusion of cho-
lesterol and other possible ﬂuid components from that network is
presumably ending in a similarly stable ﬁlm, able to sustain the max-
imal pressures without deformation, even upon receiving the shock-
ing waves of dramatic external mechanical perturbations. One could
therefore conclude that it is the presence of this fully interconnected
condensed network at the nanoscale what deﬁnes the adequate rhe-
ological properties of surfactant ﬁlms, required to provide enough
stability to the respiratory surface under the demanding conditions
imposed by breathing dynamics. A recent study has compared the
structure at the nanoscale of ﬁlms formed by different clinical surfac-
tant preparations [20]. Although the differences found in the structure
of these preparations have not been correlatedwith functional singular-
ities, it is remarkable that an interconnected network of condensed
phase similar to that described here was present in the preparations
presumably containing themost similar protein compositions to native
surfactant.
Production of Surfacen includes lyophilization of surface active lipid–
protein suspensions, which are later re-hydrated close to themoment of
surfactant administration to babies. The lyophilization process includes a
freezing step that, depending on the rate of cooling, could facilitate lipid
demixing and phase separation of the mixture of saturated and unsatu-
rated lipid species typically included in Surfacen. Membrane-cooling
procedures in the production of Surfacen could induce a particularly ef-
ﬁcient segregation of entirely solid DPPC-enriched condensed domains
in membranes and ﬁlms, as observed by epiﬂuorescence microscopy,
which could also be behind a more complex calorimetric thermogram,
with contributions extended over a wider range of temperatures, com-
pared to that of native surfactant. More solid condensed domains in
the interfacial ﬁlms might be more efﬁcient than relatively ﬂuid LO do-
mains to sustain the highest pressures during compression or to prevent
the relaxation of theﬁlms during expansion,which could be relatedwith
a relatively higher stability of Surfacen ﬁlms as observed particularly in
ﬁlms compressed at the relatively slow speeds of the Langmuir balance.
The situation under breathing conditions in vivo could be different, and
it should be determined whether the increase in ﬂuidity and dynamics
promoted by cholesterol could have alternative advantages. Additional
studies are required to fully characterize the persistence and conse-
quences of the effects of the thermal history experimented by clinical
surfactants during their production process, which could be especially
relevant to optimize properties such as the stability of the ﬁlms and
their ability to resist environmental perturbations.Acknowledgements
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